These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 17185789)

  • 41. Ovulation induction with clomiphene citrate and metformin in women with polycystic ovary syndrome.
    Leanza V; Coco L; Grasso F; Leanza G; Zarbo G; Palumbo M
    Minerva Ginecol; 2014 Jun; 66(3):299-301. PubMed ID: 24971785
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Risk of multiple gestation after ovulation induction in polycystic ovary syndrome.
    Ratts VS; Pauls RN; Pinto AB; Kraja A; Williams DB; Odem RR
    J Reprod Med; 2007 Oct; 52(10):896-900. PubMed ID: 17977162
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A randomized controlled trial of the effect of rosiglitazone and clomiphene citrate versus clomiphene citrate alone in overweight/obese women with polycystic ovary syndrome.
    Mohsen IA
    Gynecol Endocrinol; 2012 Apr; 28(4):269-72. PubMed ID: 21970545
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Long-term outcomes in women with polycystic ovary syndrome initially randomized to receive laparoscopic electrocautery of the ovaries or ovulation induction with gonadotrophins.
    Nahuis MJ; Kose N; Bayram N; van Dessel HJ; Braat DD; Hamilton CJ; Hompes PG; Bossuyt PM; Mol BW; van der Veen F; van Wely M
    Hum Reprod; 2011 Jul; 26(7):1899-904. PubMed ID: 21576081
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prognostic value of total testosterone for pregnancy during treatment in patients with clomiphene-citrate-resistant polycystic ovary syndrome: a pilot study.
    Li C; Cheng J; Wang J; Xue Y; Huang Z; Zhang S; Lv J
    Arch Gynecol Obstet; 2011 Sep; 284(3):757-64. PubMed ID: 21614496
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Ovulation induction in infertile patients with polycystic ovary syndrome.
    Palomba S; Zullo F
    Minerva Ginecol; 2006 Apr; 58(2):115-35. PubMed ID: 16582868
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Treatment of polycystic ovary syndrome and related infertility with clomiphene resistance by compound cyproterone acetate].
    Tao Y; Dai Q; Zhang D
    Zhonghua Fu Chan Ke Za Zhi; 1999 Sep; 34(9):528-32. PubMed ID: 11360636
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Treating polycystic ovary syndrome and infertility.
    McFarland C
    MCN Am J Matern Child Nurs; 2012; 37(2):116-21. PubMed ID: 22357073
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Consensus on infertility treatment related to polycystic ovary syndrome.
    Thessaloniki ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group
    Hum Reprod; 2008 Mar; 23(3):462-77. PubMed ID: 18308833
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Therapeutic strategies for ovulation induction in infertile women with polycystic ovary syndrome.
    Cristello F; Cela V; Artini PG; Genazzani AR
    Gynecol Endocrinol; 2005 Dec; 21(6):340-52. PubMed ID: 16390783
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Increase of multiple pregnancies caused by ovulation induction with gonadotropin in combination with metformin in infertile women with polycystic ovary syndrome.
    Shibahara H; Kikuchi K; Hirano Y; Suzuki T; Takamizawa S; Suzuki M
    Fertil Steril; 2007 Jun; 87(6):1487-90. PubMed ID: 17254579
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Ovulation induction with myo-inositol alone and in combination with clomiphene citrate in polycystic ovarian syndrome patients with insulin resistance.
    Kamenov Z; Kolarov G; Gateva A; Carlomagno G; Genazzani AD
    Gynecol Endocrinol; 2015 Feb; 31(2):131-5. PubMed ID: 25259724
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clomiphene citrate-resistant polycystic ovary syndrome. Preventing multifollicular development.
    Ergür AR; Yergök YZ; Ertekin A; Küçük T; Müngen E; Tütüncü L
    J Reprod Med; 1998 Mar; 43(3):185-90. PubMed ID: 9564642
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Management ofanovulatory infertility associated with polycystic ovary syndrome (PCOS).
    Sukcharoen N
    J Med Assoc Thai; 2004 Oct; 87 Suppl 3():S182-8. PubMed ID: 21213521
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pharmacology of medications used for ovarian stimulation.
    Quaas AM; Legro RS
    Best Pract Res Clin Endocrinol Metab; 2019 Feb; 33(1):21-33. PubMed ID: 30470497
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clomiphene versus metformin for ovulation induction in polycystic ovary syndrome: the winner is ...
    Barbieri RL
    J Clin Endocrinol Metab; 2007 Sep; 92(9):3399-401. PubMed ID: 17823274
    [No Abstract]   [Full Text] [Related]  

  • 57. Pretreatment and co-administration of oral anti-diabetic agent with clomiphene citrate or rFSH for ovulation induction in clomiphene-citrate-resistant polycystic ovary syndrome.
    Begum MR; Akhter S; Ehsan M; Begum MS; Khan F
    J Obstet Gynaecol Res; 2013 May; 39(5):966-73. PubMed ID: 23379651
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Should insulin-sensitizing drugs be used in the treatment of polycystic ovary syndrome?
    Cheang KI; Nestler JE
    Reprod Biomed Online; 2004 Apr; 8(4):440-7. PubMed ID: 15149568
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Polycystic ovary syndrome in the Indian Subcontinent.
    Allahbadia GN; Merchant R
    Semin Reprod Med; 2008 Jan; 26(1):22-34. PubMed ID: 18181079
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Management strategies for ovulation induction in women with polycystic ovary syndrome and known clomifene citrate resistance.
    Palomba S; Falbo A; Zullo F
    Curr Opin Obstet Gynecol; 2009 Dec; 21(6):465-73. PubMed ID: 19809318
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.